Company Active LTD

Company profile

Psyomics Ltd

Psyomics

Our technology gets to the root of mental health, helping more people find the best support for their needs, whenever they need it.

CRN
09470381
Founded
2015
Age
11

Overview

Legal name
PSYOMICS LTD
Region
East of England
Registered address
7 QUY COURT COLLIERS LANE
STOW-CUM-QUY
CAMBRIDGE
ENGLAND
CB25 9AU
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

2 levels 1 ultimate controller
1
Company Active LTD
Psyomics Ltd
CRN 09470381
2
Direct controller Active LTD
Parkwalk Advisors Ltd
CRN 06925696
3
Ultimate controller Active PLC
Ip Group PLC
CRN 04204490

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

02 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

19 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

04 Mar
2015

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2016
Funded years
2016, 2017
Age at first award
1 years

Projects

2017 Collaborative R&D Lead participant

Development of diagnostic device to differentiate between bipolar and unipolar depression

1 Nov 2017 to 30 Apr 2019

Awarded
£157,431
Total cost £224,902

Bipolar disorder affects 2.4m people in the UK alone and has an estimated prevalence of around 2% globally, yet 40% of patients with bipolar disorder are misdiagnosed with depression and it takes an average of 7.5 years for the correct diagnosis to be reached. This leads to ineffective treatments, increased suicide risk, antidepressant-induced mania and h...

2016 Procurement Lead participant

PsyOmics Quantified Health Solution

1 Apr 2016 to 31 Dec 2016

Awarded
£42,000
Total cost £42,000

PsyOmics Ltd is a biotech company that is working in collaboration with the Cambridge Centre for Neuropsychiatric Research (CCNR) to deliver improved prevention, diagnosis and treatment of psychiatric conditions. We aim to: (i) Improve treatment by providing contract research services to support clinical trials for psychiatric treatment (ii) Improve diagn...

Product types

Collaborative R&D Procurement